International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Betahistine 16-mg Capsules

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2013 - Volume 17, Number 2
View All Articles in Issue

Page(s): 146

Download in electronic PDF format for $75

Abstract: A formulation for preparing Betahistine 16-mg Capsules. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, betahistine, antivertigo agent, vertigo, balance disorders, vasodilator, Meniere disease, histamine H1 receptor agonist, histamine H3 receptor antagonist

Related Categories: EAR NOSE THROAT, FORMULATIONS, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Betahistine 16-mg Capsules Allen Loyd V Jr	Mar/Apr 2013 Pg. 146
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Book Review: The NMDA Receptor Jones Marty	Jan/Feb 2000 Pg. 26-27
Technology Spotlight: Electronic Balances with Printer and Draft Shield Wesolowski Paul	Mar/Apr 2003 Pg. 120-123
Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain Mishkan Emilyn S	Sep/Oct 2005 Pg. 339-346
Basics of Compounding for Raynaud's Disease Glasnapp Andrew	Jul/Aug 2003 Pg. 288-291
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray Allen Loyd V Jr	Mar/Apr 2016 Pg. 147
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Compounding for the Treatment of COVID-19 and Long COVID, Part 3: The Role of Toll-like Receptors in SARS-CoV-2 Infection and COVID Development Riepl Mike, Kaiser Joe	May/Jun 2023 Pg. 192-200
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Mar/Apr 2024 Pg. 100-109
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Wu George, Powers Dan, Yeung Stanley, Chen Frank	Jan/Feb 2018 Pg. 76-85
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly	Jan/Feb 2018 Pg. 86-94
Treating Inner Ear Disorders with Intratympanic Drug Administration McElhiney Linda F	Jul/Aug 2011 Pg. 302-307
Treating Canine Hepatic Disease Davidson Gigi S	May/Jun 2003 Pg. 188-191
Aprepitant 80-mg Capsules Allen Loyd V Jr	Jan/Feb 2016 Pg. 48
Valsartan 16-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2019 Pg. 237
Famotidine 8-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2006 Pg. 382
Antique Pharmaceutical Balances Richardson Charles G	Jul/Aug 1999 Pg. 280-283
Return to Top